Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
success tags : Therapy save search
Kyowa Kirin successfully completes acquisition of Orchard Therapeutics, a global gene therapy leader for rare diseases
Published: 2024-01-24 (Crawled : 10:00) - globenewswire.com
ORTX | $16.7 0.0% 370K
|
Health Technology
| Email alert
Add to watchlist
rare acquisition global therapy
Therapeutic Solutions International Launches VasoSome Vascular Inc Based on Successful Treatment of Aortic Aneurysms using Patent Pending Exosome Therapy
Published: 2023-05-01 (Crawled : 15:00) - biospace.com/
TSOI | $0.0007 0.0% 13M
|
Manufacturing
|
| O: 10.34%
H: 0.0%
C: -18.75%
patent international treatment solutions therapy
Study Published in "Military Medicine" Reports 88% Success Treating Obstructive Sleep Apnea Patients with Precision Oral Appliance Therapy
Published: 2022-12-08 (Crawled : 15:20) - biospace.com/
OSA | $0.5 -4.56% -4.78% 59K
|
n/a
|
| O: 6.62%
H: 0.0%
C: -16.41%
success therapy study
Mustang Bio Announces First Patient Successfully Treated by Ex Vivo Lentiviral Gene Therapy to Treat RAG1 Severe Combined Immunodeficiency
Published: 2022-07-27 (Crawled : 14:00) - biospace.com/
MBIO | $0.3819 -0.55% -1.05% 200K
|
Health Technology
|
| O: -1.54%
H: 7.81%
C: 3.42%
FBIO | $1.81 2.26% 2.21% 440K
|
Health Technology
|
| O: 3.07%
H: 0.88%
C: -0.22%
therapy
Global Oncology Targeted Immunotherapy Market Report 2021: Rising Success of Gene and Cell Therapies, Gene Editing Techniques, and Novel Gene Delivery Platforms
Published: 2022-01-17 (Crawled : 21:00) - prnewswire.com
JNCE | $1.88 -2.59% -1.85% 0
|
Health Technology
|
| O: -1.91%
H: 1.95%
C: -0.65%
INBX | $34.47 -0.41% -0.41% 420K
|
Health Technology
|
| O: -2.1%
H: 0.75%
C: -9.51%
BNTX | $86.19 -0.24% -0.24% 580K
|
Health Technology
|
| O: -6.49%
H: 0.0%
C: -7.66%
liver cel immunotherapy report therapy platform
Therapeutic Solutions International Successfully Treats “No Option” Patients with its JadiCell™ Stem Cell Therapy While Advancing Preparations for Phase III COVID-19 Clinical Trial
Published: 2021-12-30 (Crawled : 16:00) - biospace.com/
TSOI | $0.0007 0.0% 13M
|
Manufacturing
|
| O: 4.48%
H: 5.71%
C: -10.29%
covid-19 trial covid cel stem cell therapy
Immutep Successfully Completes Recruitment for Phase II TACTI-002 Study of LAG-3 Therapy, Eftilagimod Alpha
Published: 2021-11-19 (Crawled : 13:30) - globenewswire.com
IMMP | News | $2.205 -2.43% -2.73% 270K
|
Health Technology
|
| O: -0.51%
H: 1.82%
C: -1.55%
therapy
Sio Gene Therapies Announces Successful Manufacture of Three GMP Batches of AXO-Lenti-PD Gene Therapy for Parkinson’s Disease
Published: 2021-11-11 (Crawled : 14:00) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 2.07%
H: 2.54%
C: 2.03%
disease gene therapies gene therapy therapy parkinson
Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients' Duration of Therapy by 40%, Promoting Successful Treatment
Published: 2021-10-29 (Crawled : 11:00) - prnewswire.com
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
|
| O: 0.59%
H: 0.0%
C: -2.34%
treatment therapy cancer liver
Pasithea Therapeutics Announces Successful Treatment of First Patients in the UK with Ketamine Infusion Therapy– Pasithea Clinics
Published: 2021-10-27 (Crawled : 12:15) - biospace.com/
KTTA | $7.15 -1.19% 700
|
|
| O: 2.95%
H: 43.37%
C: 6.09%
treatment therapy ketamine depression
Pasithea Therapeutics Announces Successful Treatment of First Patients in the UK with Ketamine Infusion Therapy
Published: 2021-10-27 (Crawled : 12:00) - globenewswire.com
KTTA | $7.15 -1.19% 700
|
|
| O: 2.95%
H: 43.37%
C: 6.09%
treatment therapy ketamine
Cryopreservation: A Key Element in the Successful Delivery of GMP Cell Therapies
Published: 2021-09-09 (Crawled : 13:00) - thermogenesis.com
THMO | $0.613 -2.7% -2.77% 21K
|
Health Technology
|
| O: -0.84%
H: 4.24%
C: -2.12%
cryo liver therapy
Abeona Therapeutics Announces Successful Type B Meeting with U.S. FDA for ABO-102 AAV-based Gene Therapy in Sanfilippo Syndrome Type A (MPS IIIA)
Published: 2021-07-28 (Crawled : 12:00) - globenewswire.com
ABEO | $7.55 -4.79% -5.03% 250K
|
Health Technology
|
| O: 2.4%
H: 4.69%
C: 0.0%
fda gene therapy therapy aav9 gene therapies aβos syndros
Ultragenyx Completes Successful End-of-Phase 2 Meeting with FDA and Finalizes Phase 3 Study Design for DTX301 Ornithine Transcarbamylase (OTC) Gene Therapy ProgramPhase 3 Study on Track to Initiate in Second Half 2021
Published: 2021-04-22 (Crawled : 14:00) - biospace.com/
RARE F | $43.38 -1.65% -1.68% 770K
|
Health Technology
|
| O: 0.39%
H: 2.14%
C: -0.64%
fda phase 2 gene therapy therapy phase 3 gene therapies designation
Freeline Appoints Colin Love, PhD to Board of DirectorsExperienced biopharmaceutical executive with established record of successfully developing, manufacturing and launching impactful therapies
Published: 2021-03-11 (Crawled : 14:01) - biospace.com/
FRLN | $6.48 0.0% 0
|
Health Technology
|
| O: 3.71%
H: 0.0%
C: -3.17%
biopharma therapy
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.